...
首页> 外文期刊>Biomedical Microdevices >Quantification of kinase activity in cell lysates via photopatterned macroporous poly(ethylene glycol) hydrogel arrays in microfluidic channels
【24h】

Quantification of kinase activity in cell lysates via photopatterned macroporous poly(ethylene glycol) hydrogel arrays in microfluidic channels

机译:通过微流控通道中的光图案化大孔聚乙二醇水凝胶阵列定量分析细胞裂解物中的激酶活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The efficacy of tyrosine kinase inhibitors (TKIs) as cancer therapeutics varies amongst individual patients as a result of patient-specific differences in molecular regulation of cancer development and progression, and acquisition of resistance to TKIs during therapy. A sensitive assay that can quantify kinase activity and predict inhibition of that activity from minimally invasive patient tissue samples may aid design of efficacious individualized TKI treatments. A microfluidic format can be useful in reducing limitations in standard protein kinase assays, including sensitivity required and low sample volume available. We present photopattemed macroporous poly(ethylene glycol) diacrylate hydrogel pillars functionalized with kinase substrates within microchannels for quantifying kinase activity in complex cellular lysates. We determined the effect of using a porogen to induce macroporosity in hydrogel pillars and showed that hydrogel poration enhanced the sensitivity of detecting Bcr-Abl activity in cell lysates by an order of magnitude. Bcr-Abl tyrosine kinase activity in K562 cell lysates could be detected from 0.01 μg/(J.L of cell lysate, corresponding to approximately 500 cells, using GST-Crkl immobilized in macroporous hydrogels. This device was also capable of quantifying inhibition of Bcr-Abl activity by imatinib mesylate, which demonstrates the potential to predict the biochemical response to drug inhibitors. These results indicate that microfluidic devices containing macroporous hydrogels functionalized with kinase substrates provide a promising platform for sensitive and specific quantification of kinase activity and efficacy of kinase inhibitors in cancer cell lysates.
机译:酪氨酸激酶抑制剂(TKIs)作为癌症治疗剂的疗效因患者个体对癌症发展和进展的分子调节以及治疗期间获得的对TKIs耐药性的差异而在个体患者中有所不同。可以量化激酶活性并预测来自微创患者组织样品的该活性的抑制的灵敏测定法可以帮助设计有效的个性化TKI治疗。微流体形式可用于减少标准蛋白激酶测定的限制,包括所需的灵敏度和可用的少量样品。我们介绍了photopatterned大孔聚(乙二醇)二丙烯酸酯水凝胶支柱功能化微通道内的激酶底物定量复杂细胞裂解物中的激酶活性。我们确定了使用致孔剂在水凝胶柱中诱导大孔的效果,并显示水凝胶渗透将细胞裂解物中Bcr-Abl活性的检测灵敏度提高了一个数量级。使用固定在大孔水凝胶中的GST-Crkl,可以从0.01μg/(JL细胞裂解物中,对应于大约500个细胞)检测K562细胞裂解物中的Bcr-Abl酪氨酸激酶活性。该装置也能够定量抑制Bcr-Abl甲磺酸伊马替尼的活性表明了预测对药物抑制剂的生化反应的潜力,这些结果表明,含有大分子水凝胶的微流体装置已被激酶底物功能化,为敏感性和特异性定量激酶活性和癌症抑制剂的功效提供了有希望的平台细胞裂解物。

著录项

  • 来源
    《Biomedical Microdevices》 |2012年第2期|p.247-257|共11页
  • 作者单位

    Department of Chemical and Biological Engineering, University of Wisconsin-Madison, 1415 Engineering Drive, Madison, WI 53706, USA;

    Department of Biomedical Engineering, University of Wisconsin-Madison, 1550 Engineering Drive, Madison, WI 53706, USA;

    Department of Chemical and Biological Engineering, University of Wisconsin-Madison, 1415 Engineering Drive, Madison, WI 53706, USA,Department of Biomedical Engineering, University of Wisconsin-Madison, 1550 Engineering Drive, Madison, WI 53706, USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    kinase activity; cancer diagnostic; microfluidic device; hydrogels;

    机译:激酶活性癌症诊断;微流体装置水凝胶;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号